The BSH Guidelines Official Podcast
By British Society for Haematology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by British Society for Haematology
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 80
Description
Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases.
Self accreditation
Listen to two podcasts and earn one CPD point via self-accreditation
Join our Guidelines Newsletter to be notified when new guidelines/good practice papers are published by going into your members account under MyBSH. Non members can email bshguidelines@b-s-h.org.uk to sign up for updates.
| Episode | Date |
|---|---|
|
Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children
|
Dec 08, 2025 |
|
Clinical management of bispecific antibody therapy for lymphoma Guideline podcast
|
Dec 08, 2025 |
|
Lymphoma SIG Podcast Episode 16 Choosing the optimal therapy in CLL – by Dr Toby Eyre
|
Nov 07, 2025 |
|
James Griffin Podcast - Apheresis Guideline
|
Sep 08, 2025 |
|
Podcast - Guidelines on the investigation and management of antiphospholipid syndrome
|
Aug 06, 2025 |
|
Central nervous system prophylaxis in large B-cell lymphoma
|
Jul 17, 2025 |
|
Management of relapsed or refractory large B-cell lymphoma
|
Jul 17, 2025 |
|
Lymphoma SIG Podcast Episode 15
|
Jul 11, 2025 |
|
Lymphoma Sig Podcast Episode 14 Mantle cell lymphoma – first-line treatment in 2025 – by Dr David Lewis
|
Jul 04, 2025 |
|
Lymphoma SIG Podcast 13 – BSH 2025 Highlights – Top Abstracts in Lymphoma with Dr Cathy Burton
|
Jun 27, 2025 |
|
Lymphoma SIG Podcast 12 – BSH 2025 Highlights in CLL with Dr Dima El-Sharkawi
|
Jun 20, 2025 |
|
Diagnosis and management of monoclonal gammopathy of renal significance
|
Jun 13, 2025 |
|
Lymphoma SIG Podcast 11 - BSH 2025 Highlights - Dr Sridhar Chaganti updates regarding large B cell lymphoma
|
Jun 06, 2025 |
|
Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays
|
Jun 03, 2025 |
|
Lymphoma SIG Podcast 10 - BSH 2025 Highlights in Hodgkin Lymphoma with Professor Graham Collinsfirst line therapy for Hodgkins lymphoma
|
May 23, 2025 |
|
Lymphoma SIG Podcast 9 - Primary Mediastinal B-Cell lymphoma
|
May 16, 2025 |
|
Lymphoma SIG Podcast 8 - Bispecific T-cells engagers in Lymphoma
|
May 09, 2025 |
|
Lymphoma SIG Podcast 7 - Supportive Care in Lymphoma
|
May 02, 2025 |
|
Lymphoma SIG Podcast 6 - Mycosis fungoides
|
Apr 25, 2025 |
|
Lymphoma SIG Podcast 5 - T-cell lymphomas
|
Apr 23, 2025 |
|
Lymphoma SIG Podcast 4 - Management of post-transplant lymphoproliferative disorder
|
Apr 11, 2025 |
|
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma GPP
|
Feb 21, 2025 |
|
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
|
Feb 21, 2025 |
|
Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients
|
Feb 14, 2025 |
|
2024-11-06-Podcast-Keith_Gomez-Cancer_Associated_Venous-Thrombosis
|
Nov 06, 2024 |
|
Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes
|
Oct 14, 2024 |
|
Diagnosis and management of smouldering myeloma
|
Sep 24, 2024 |
|
The assessment and management of bleeding risk prior to invasive procedures
|
Jul 22, 2024 |
|
The management of myelofibrosis: A British Society for Haematology Guideline
|
Jul 22, 2024 |
|
Podcast- Guidelines for the specification, implementation and management of IT systems in hospital transfusion laboratories-Julie Staves
|
Jul 12, 2024 |
|
Graham McIlroy Podcast - The management of newly diagnosed large B-cell lymphoma
|
May 14, 2024 |
|
Diagnosis and management of heparin-induced thrombocytopenia: Third edition
|
Apr 19, 2024 |
|
Diagnosis and management of marginal zone lymphomas
|
Apr 08, 2024 |
|
Guideline on the Investigation and management of a raised serum ferritin
|
Apr 04, 2024 |
|
Significant Haemoglobinopathies: a guideline for screening and diagnosis
|
Nov 29, 2023 |
|
Diagnosis and management of Mantle Cell Lymphoma
|
Nov 21, 2023 |
|
Investigation and management of the monoclonal gammopathy of undetermined significance (MGUS)
|
Aug 02, 2023 |
|
Guideline on the investigation and management of acute transfusion reactions
|
Jul 12, 2023 |
|
Haematological management of major haemorrhage
|
Jun 07, 2023 |
|
Anticoagulant management of pregnant individuals with mechanical heart valves
|
May 26, 2023 |
|
EHA 2022: The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper
|
Dec 21, 2022 |
|
Management of secondary central nervous system lymphoma: A British Society for Haematology Good Practice Paper
|
Dec 08, 2022 |
|
Guidelines for thrombophilia testing
|
Nov 28, 2022 |
|
Good Practice Paper for management of older patients with frailty and acute myeloid leukaemia
|
Aug 26, 2022 |
|
Guideline for the first-line management of Classical Hodgkin Lymphoma
|
Jul 19, 2022 |
|
BSH ASM: Guidelines Session: GPP Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients
|
Jun 30, 2022 |
|
BSH ASM: Guidelines Session Presentation: Preoperative patient blood management during the SARS-CoV-2 pandemic
|
Jun 27, 2022 |
|
BSH ASM: Guidelines Session Presentation: Myelodysplastic syndromes
|
Jun 23, 2022 |
|
BSH ASM: Guidelines Session Presentation Diagnosis and Management of Waldenstrom Macroglobulinaemia
|
Jun 20, 2022 |
|
Guideline for the treatment of chronic lymphocytic leukaemia
|
Jun 13, 2022 |
|
The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper
|
Jun 07, 2022 |
|
Guidelines for the Laboratory diagnosis of malaria
|
May 27, 2022 |
|
Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias
|
May 03, 2022 |
|
Good Practice Paper for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children
|
Apr 22, 2022 |
|
Guidelines on the diagnosis and management of Waldenström macroglobulinaemia
|
Jan 20, 2022 |
|
Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)
|
Dec 02, 2021 |
|
Guideline on The management of Castleman disease
|
Oct 27, 2021 |
|
Good Practice Paper Richter transformation of chronic lymphocytic leukaemia
|
Oct 25, 2021 |
|
Good Practice Paper: Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients
|
Oct 07, 2021 |
|
Good Practice Paper: Management of cardiovascular complications of bruton tyrosine kinase inhibitors (BTKi)
|
Sep 13, 2021 |
|
Guidelines for the clinical and laboratory diagnosis of heritable platelet disorders in adults and children
|
Aug 27, 2021 |
|
Guideline on Management of sickle cell disease in pregnancy
|
Aug 20, 2021 |
|
Guidelines for the management of adult myelodysplastic syndromes
|
Jun 29, 2021 |
|
BSH ASM: Guidelines Session Question and Answer for General Haematology Presentations
|
May 26, 2021 |
|
BSH ASM: Guidelines Session Presentation GPP The use genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
|
May 26, 2021 |
|
BSH ASM: Guidelines Session Presentation GL Management of sickle cell disease in pregnancy
|
May 26, 2021 |
|
BSH ASM: Guidelines Session Question and Answer for Haemostasis and Thrombosis Presentation
|
May 26, 2021 |
|
BSH ASM: Guideline Session Presentation GL Laboratory investigation of heritable disorders of platelets function by Keith Gomez
|
May 25, 2021 |
|
Good Practice Paper Preoperative patient blood management during the SARS-CoV-2 pandemic
|
May 10, 2021 |
|
Guidelines on the diagnosis, investigation and initial treatment of myeloma
|
Apr 12, 2021 |
|
Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V)
|
Feb 22, 2021 |
|
Guideline Frontline Management of Post Transplantation Lymphoproliferative Disorder in Adult Solid Organ Recipient Patients
|
Feb 22, 2021 |
|
Guideline The use of prophylactic factor replacement for children and adults with Haemophilia A and B
|
Feb 22, 2021 |
|
Guideline on the investigation and management of follicular lymphoma
|
Feb 22, 2021 |
|
Guideline on Laboratory aspects of assays used in haemostasis and thrombosis
|
Feb 22, 2021 |
|
Good Practice Paper: The prevention of central nervous system relapsed in diffuse large B- cell lymphoma
|
Feb 19, 2021 |
|
Guideline on the diagnosis and management of chronic myeloid leukaemia
|
Feb 19, 2021 |
|
Guidelines on the use of irradiated blood components
|
Feb 19, 2021 |
|
Guideline for the management of mantle cell lymphoma
|
Feb 19, 2021 |
|
UK guidelines on the management of iron deficiency in pregnancy
|
Jan 28, 2021 |